# Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

> **NCT07532707** · NA · COMPLETED · sponsor: **Damascus University** · enrollment: 50 (actual)

## Conditions studied

- Myasthenic Crisis
- Myasthenia Gravis (MG)

## Interventions

- **BIOLOGICAL:** IVIG (Intravenous Immunoglobulin)
- **PROCEDURE:** Plasma exchange (PE)

## Key facts

- **NCT ID:** NCT07532707
- **Lead sponsor:** Damascus University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2023-10-15
- **Final completion:** 2023-10-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07532707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07532707, "Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07532707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*